Successful treatment of humeral shaft nonunion with romosozumab: A case report Dr Supreeth D R18 April 2022 3:30 AM GMTJapan: Romosozumab is a humanized monoclonal anti-sclerostin antibody (Scl-Ab) that binds and inhibits sclerostin, thereby increasing bone formation...
Romosozumab Effective in RA and Primary Osteoporosis: Study Dr. Shravani Dali26 Oct 2021 3:30 AM GMTRomosozumab increased bone mineral density (BMD) and decreased bone turnover in patients with co-occurring rheumatoid arthritis and osteoporosis...
Romosozumab substantially builds bone mineral density in hip and spine Hina Zahid13 Jan 2021 12:00 PM GMTATLANTA - New research presented at ACR Convergence, the American College Rheumatology's annual meeting, reveals that romosozumab, an osteoporosis...
Using Romosozumab prior to Antiresorptive Medication tied to better BMD gains: Study Dr. Nandita Mohan29 Dec 2020 2:25 AM GMTAccording to recent research, investigators have found that treatment with Romosozumab first produces substantial BMD gains at the total hip and...
Romosozumab offers significant benefit in osteoporosis in post menopausal women Hina Zahid16 Jun 2020 11:55 AM GMTRomosozumab offers significant benefit leading to fewer vertebral fractures and fewer other typical fractures in high risk postmenopausal women with...
